Announce Date | 05/06/2025 |
EPS Normalized Actual | $1.54 (Beat by $0.49) |
EPS GAAP Actual | $1.54 (Beat by $0.49) |
Revenue Actual | $1.895B |
Revenue Surprise | Beat by $1895M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.4181 |
EPS GAAP Estimate | $0.4181 |
Revenue Estimate | $1.257403808B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2030 | 16.12 | 9.64 | 14.70409 | 17.14798 | 6 |
Mar 2029 | 11.5 | 13.51 | 11.01331 | 12.02283 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.969 | 0.969 | 1.895B | 6.12% | 1895M |
FQ4 2024 (Dec 2024) | 1.11 | 1.11 | 1.89B | -2.91% | 1890M |
FQ3 2024 (Sep 2024) | 1.11 | 1.11 | 2.032B | 5.81% | 2032M |
FQ2 2024 (Jun 2024) | 266 | 266 | 1.66B | -15.9% | 1660M |
FQ1 2024 (Mar 2024) | 267 | 267 | 1.779B | -5.34% | 1779M |
FQ4 2023 (Dec 2023) | 269 | 269 | 1.945B | 3.29% | 1945M |
FQ3 2023 (Sep 2023) | 1.47 | 1.47 | 1.914B | 0.52% | 1914M |
FQ2 2023 (Jun 2023) | 1.48 | 1.48 | 1.924B | 8.16% | 1924M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.4181
Consensus Revenue Estimates
1.257403808B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.46923 | -- | 4.34976 | 4.64556 | 6 |
FQ3 2027 (Sep 2027) | 2.35562 | -- | 2.29265 | 2.44856 | 3 |
FQ2 2027 (Jun 2027) | 0.49678 | -- | 0.4835 | 0.51638 | 5 |
FQ1 2027 (Mar 2027) | 2.19504 | -- | 2.09012 | 2.24188 | 5 |
FQ4 2026 (Oct 2026) | 2.28099 | -- | 2.12706 | 2.55914 | 7 |
FQ3 2026 (Jul 2026) | 0.65626 | -- | 0.61197 | 0.73629 | 4 |
FQ2 2026 (Jun 2026) | 0.65626 | -- | 0.60807 | 0.74535 | 9 |
FQ1 2026 (Mar 2026) | 1.94381 | 50.15 | 1.67111 | 2.28127 | 6 |
FQ4 2025 (Oct 2025) | 2.01658 | 44.96 | 1.88049 | 2.26249 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.73B | -- | 2.67B | 2.81B | 6 |
FQ3 2027 (Sep 2027) | 2.21B | -- | 2.17B | 2.28B | 6 |
FQ2 2027 (Jun 2027) | 1.37B | -- | 1.35B | 1.42B | 6 |
FQ1 2027 (Mar 2027) | 1.97B | -- | 1.9B | 2B | 5 |
FQ4 2026 (Oct 2026) | 2.21B | -- | 2.09B | 2.41B | 8 |
FQ3 2026 (Jul 2026) | 1.49B | -- | 1.41B | 1.63B | 5 |
FQ2 2026 (Jun 2026) | 1.49B | -- | 1.41B | 1.65B | 6 |
FQ1 2026 (Mar 2026) | 2.03B | 6.77 | 1.81B | 2.3B | 7 |
FQ4 2025 (Oct 2025) | 2.08B | 8.94 | 1.97B | 2.27B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.969 | 0.969 | 100% | |
FQ4 2024 (Dec 2024) | 1.11 | 1.11 | 100% | |
FQ3 2024 (Sep 2024) | 1.11 | 1.11 | 100% | |
FQ2 2024 (Jun 2024) | 266 | 266 | 100% | |
FQ1 2024 (Mar 2024) | 267 | 267 | 100% | |
FQ4 2023 (Dec 2023) | 269 | 269 | 100% | |
FQ3 2023 (Sep 2023) | 1.47 | 1.47 | 100% | |
FQ2 2023 (Jun 2023) | 1.48 | 1.48 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.9B | $1895M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.89B | $1890M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.03B | $2032M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.66B | $1660M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.78B | $1779M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.95B | $1945M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.91B | $1914M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.92B | $1924M | 100% |